Prof. Dr. Andreas Cerny
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.
Moschouri E, Salemme G, Baserga A, Cerny A, Deibel A, Muellhaupt B, Meier M, Bernsmeier C, Ongaro M, Negro F, Grosjean M, Clerc O, Künzler-Heule P, Semela D, Hobi G, Stickel F, Mathieu A, Mdawar-Bailly E, Faouzi M, Moradpour D, Fraga M. Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis. Swiss Med Wkly 2024; 154:3698.
Jun 24, 2024Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.
Jun 24, 2024Swiss Med Wkly 2024; 154:3698
Moschouri Eleni, Salemme Gloria, Baserga Adriana, Cerny Andreas, Deibel Ansgar, Muellhaupt Beat, Meier Marie-Anne, Bernsmeier Christine, Ongaro Marie, Negro Francesco, Grosjean Marielle, Clerc Olivier F, Künzler-Heule Patrizia, Semela David, Hobi Gabriel, Stickel Felix, Mathieu Adeline, Mdawar-Bailly Elise, Faouzi Mohamed, Moradpour Darius, Fraga Montserrat
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Ludz C, Stirnimann G, Semela D, Mertens J, Kremer A, Filipowicz Sinnreich M, Sokollik C, Bernsmeier C, Bresson-Hadni S, McLin V, Rock N, Braegger C, Posovszky C, Müller P, Cremer M, De Gottardi A, Galante A, Furlano R, Righini-Grunder F, Becker B, Böhm S, Heyland K, Nydegger A, Limoni C, Vergani D, Mieli-Vergani G, Di Bartolomeo C, Cerny A, Terziroli Beretta-Piccoli B. Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study. Swiss Med Wkly 2023; 153:40102.
Aug 31, 2023Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Aug 31, 2023Swiss Med Wkly 2023; 153:40102
Ludz Christine, Stirnimann Guido, Semela David, Mertens Joachim C, Kremer Andreas E, Filipowicz Sinnreich Magdalena, Sokollik Christiane, Bernsmeier Christine, Bresson-Hadni Solange, McLin Valérie, Rock Nathalie, Braegger Christian P, Posovszky Carsten, Müller Pascal, Cremer Matthias, De Gottardi Andrea, Galante Antonio, Furlano Raoul, Righini-Grunder Franziska, Becker Björn, Böhm Stephan, Heyland Klaas, Nydegger Andreas, Limoni Costanzo, Vergani Diego, Mieli-Vergani Giorgina, Di Bartolomeo Claudia, Cerny Andreas, Terziroli Beretta-Piccoli Benedetta
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
Albrich W, Ghosh T, Ahearn-Ford S, Mikaeloff F, Lunjani N, Forde B, Suh N, Kleger G, Pietsch U, Frischknecht M, Garzoni C, Forlenza R, Horgan M, Sadlier C, Negro T, Pugin J, Wozniak H, Cerny A, Neogi U, O'Toole P, O'Mahony L. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2. Gut Microbes 2022; 14:2073131.
Jan 1, 2022A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
Jan 1, 2022Gut Microbes 2022; 14:2073131
Albrich Werner, Ghosh Tarini Shankar, Ahearn-Ford Sinead, Mikaeloff Flora, Lunjani Nonhlanhla, Forde Brian, Suh Noémie, Kleger Gian-Reto, Pietsch Urs, Frischknecht Manuel, Garzoni Christian, Forlenza Rossella, Horgan Mary, Sadlier Corinna, Negro Tommaso Rochat, Pugin Jérôme, Wozniak Hannah, Cerny Andreas, Neogi Ujjwal, O'Toole Paul W, O'Mahony Liam
Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C
Bobzin C, Semmo N, Semela D, Scheidegger C, Rauch A, Negro F, Moradpour D, Mäschli B, Lavanchy D, Künzler-Heule P, Keiser O, Fraga Christinet M, Cerny A, Bruggmann P, Bösiger C, Thurnheer M. Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C. Swiss Medical Forum 2021; 21:184-186.
Mar 17, 2021Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C
Mar 17, 2021Swiss Medical Forum 2021; 21:184-186
Bobzin Carina, Semmo Nasser, Semela David, Scheidegger Claude, Rauch Andri, Negro Francesco, Moradpour Darius, Mäschli Bettina, Lavanchy D, Künzler-Heule Patrizia, Keiser Olivia, Fraga Christinet Montserrat, Cerny Andreas, Bruggmann Philip, Bösiger Christophe, Thurnheer Maria Christine
Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Costantini S, Cerny A, Messina P, Di Bartolomeo C, Merlo E, Kolbus N, Voreck A, Mazzucchelli L, Zen Y, Semela D, Mertens J, Stirnimann G, Swiss PBC Cohort Study Group. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines. J Autoimmun 2020; 116:102578.
Nov 20, 2020Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines
Nov 20, 2020J Autoimmun 2020; 116:102578
Terziroli Beretta-Piccoli Benedetta, Mieli-Vergani Giorgina, Vergani Diego, Costantini Silvia, Cerny Andreas, Messina Paola, Di Bartolomeo Claudia, Merlo Elisabetta, Kolbus Norbert, Voreck Anja, Mazzucchelli Luca, Zen Yoh, Semela David, Mertens Joachim, Stirnimann Guido, Swiss PBC Cohort Study Group
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
Roelens M, Keiser O, Negro F, Junker C, Semela D, Clerc O, Mullhaupt B, Schmid P, Semmo N, Cerny A, Moradpour D, Bertisch B, Swiss Hepatitis C Cohort Study. All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS). Open Forum Infect Dis 2020; 7:ofaa308.
Jul 25, 2020All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
Jul 25, 2020Open Forum Infect Dis 2020; 7:ofaa308
Roelens Maroussia, Keiser Olivia, Negro Francesco, Junker Christoph, Semela David, Clerc Olivier, Mullhaupt Beat, Schmid Patrick, Semmo Nasser, Cerny Andreas, Moradpour Darius, Bertisch Barbara, Swiss Hepatitis C Cohort Study
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030
Goossens N, Semela D, Razavi H, Negro F, Muellhaupt B, Moriggia A, Mertens J, Jornayvaz F, Dufour J, Cerny A, Bellentani S, Estes C. Nonalcoholic fatty liver disease burden - Switzerland 2018-2030. Swiss Med Wkly 2019; 149:w20152.
Dec 17, 2019Nonalcoholic fatty liver disease burden - Switzerland 2018-2030
Dec 17, 2019Swiss Med Wkly 2019; 149:w20152
Goossens Nicolas, Semela David, Razavi Homie, Negro Francesco, Muellhaupt Beat, Moriggia Alberto, Mertens Joachim, Jornayvaz François R, Dufour Jean-François, Cerny Andreas, Bellentani Stefano, Estes Chris
Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents
Terziroli Beretta-Piccoli B, Muratori L, Vergani D, Mieli-Vergani G, Moradpour D, Semela D, Semmo N, Mertens J, Cerny A, Melidona L, Tesei C, Silvestri T, Grondona A, Deleonardi G, Di Bartolomeo C, Swiss Hepatitis C Cohort Study. Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. J Autoimmun 2019; 102:89-95.
Apr 30, 2019Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents
Apr 30, 2019J Autoimmun 2019; 102:89-95
Terziroli Beretta-Piccoli Benedetta, Muratori Luigi, Vergani Diego, Mieli-Vergani Giorgina, Moradpour Darius, Semela David, Semmo Nasser, Mertens Joachim, Cerny Andreas, Melidona Laura, Tesei Cinzia, Silvestri Tania, Grondona Ana Gabriela, Deleonardi Gaia, Di Bartolomeo Claudia, Swiss Hepatitis C Cohort Study
Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland
Terziroli Beretta-Piccoli B, Carbone M, Invernizzi P, Baserga A, Oneta C, Filipowicz Sinnreich M, Giostra E, Bihl F, Kalid-de Bakker C, Stickel F, Helbling B, Hessler R, Semela D, Cerny A, Stirnimann G, Mertens J. Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland. Clin Rev Allergy Immunol 2017
Nov 27, 2017Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland
Nov 27, 2017Clin Rev Allergy Immunol 2017
Terziroli Beretta-Piccoli Benedetta, Carbone Marco, Invernizzi Pietro, Baserga Adriana, Oneta Carl, Filipowicz Sinnreich Magdalena, Giostra Emiliano, Bihl Florian, Kalid-de Bakker Carolina, Stickel Felix, Helbling Beat, Hessler Roxane, Semela David, Cerny Andreas, Stirnimann Guido, Mertens Joachim
A systematic review and meta-analysis of HCV clearance
Gauthiez E, Moradpour D, Mullhaupt B, Negro F, Semela D, Semmo N, Villard J, Bibert S, Bochud P, Malinverni R, Heim M, Habfast-Robertson I, Rüeger S, Kutalik Z, Aubert V, Berg T, Cerny A, Gorgievski M, George J, Swiss Hepatitis C Cohort Study. A systematic review and meta-analysis of HCV clearance. Liver Int 2017; 37:1431-1445.
Mar 30, 2017A systematic review and meta-analysis of HCV clearance
Mar 30, 2017Liver Int 2017; 37:1431-1445
Gauthiez Emeline, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Semela David, Semmo Nasser, Villard Jean, Bibert Stéphanie, Bochud Pierre-Yves, Malinverni Raffaele, Heim Markus H, Habfast-Robertson Ines, Rüeger Sina, Kutalik Zoltán, Aubert Vincent, Berg Thomas, Cerny Andreas, Gorgievski Meri, George Jacob, Swiss Hepatitis C Cohort Study
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2015; 6:7280.
Jun 29, 2015Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Jun 29, 2015Nat Commun 2015; 6:7280
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2014; 5:5699.
Dec 23, 2014Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Dec 23, 2014Nat Commun 2014; 5:5699
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development
Lange C, Negro F, Semela D, Kutalik Z, Müller T, Spengler U, Berg T, Chayama K, Moradpour D, Bochud P, Hiroshima Liver Study Group, Mullhaupt B, Malinverni R, Heim M, Miki D, Ochi H, Nischalke H, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour J, Gorgievski-Hrisoho M, Swiss Hepatitis C Cohort Study Group. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PloS one 2013; 8:e64053.
May 29, 2013Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development
May 29, 2013PloS one 2013; 8:e64053
Lange Christian M, Negro Francesco, Semela David, Kutalik Zoltán, Müller Tobias, Spengler Ulrich, Berg Thomas, Chayama Kazuaki, Moradpour Darius, Bochud Pierre-Yves, Hiroshima Liver Study Group, Mullhaupt Beat, Malinverni Raffaele, Heim Markus H, Miki Daiki, Ochi Hidenori, Nischalke Hans-Dieter, Bojunga Jörg, Bibert Stéphanie, Morikawa Kenichi, Gouttenoire Jérôme, Cerny Andreas, Dufour Jean-François, Gorgievski-Hrisoho Meri, Swiss Hepatitis C Cohort Study Group
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
Lange C, Bochud P, Kutalik Z, Moradpour D, Semela D, Negro F, Mullhaupt B, Malinverni R, Kaiser L, Heim M, Cerny A, Cellerai C, Dufour J, Bibert S, Swiss Hepatitis C Cohort Study Group. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J Hepatol 2013; 59:504-9.
May 9, 2013Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
May 9, 2013J Hepatol 2013; 59:504-9
Lange Christian M, Bochud Pierre-Yves, Kutalik Zoltán, Moradpour Darius, Semela David, Negro Francesco, Mullhaupt Beat, Malinverni Raffaele, Kaiser Laurent, Heim Markus H, Cerny Andreas, Cellerai Cristina, Dufour Jean-François, Bibert Stéphanie, Swiss Hepatitis C Cohort Study Group
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma
Kuske L, Dufour J, Cerny A, Malinverni R, Heim M, Malé P, Moradpour D, Semela D, Negro F, Mullhaupt B, Mensen A, Swiss Hepatitis C Cohort Study. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. Swiss Med Wkly 2012; 142:w13651.
Aug 6, 2012Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma
Aug 6, 2012Swiss Med Wkly 2012; 142:w13651
Kuske Lorenz, Dufour Jean-François, Cerny Andreas, Malinverni Raffaele, Heim Markus H, Malé Pierre Jean, Moradpour Darius, Semela David, Negro Francesco, Mullhaupt Beat, Mensen Armand, Swiss Hepatitis C Cohort Study
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection
Patin E, Stewart G, Booth D, George J, Casanova J, Bréchot C, Rice C, Talal A, Jacobson I, Bourlière M, Theodorou I, Poynard T, Negro F, Pol S, Bochud P, Abel L, Swiss Hepatitis C Cohort Study Group, International Hepatitis C Genetics Consortium, Suppiah V, Martinetti G, Hirsch H, Kutalik Z, Guergnon J, Bibert S, Nalpas B, Jouanguy E, Munteanu M, Bousquet L, Argiro L, Halfon P, Boland A, Mullhaupt B, Semela D, Dufour J, Heim M, Moradpour D, Cerny A, Malinverni R, French ANRS HC EP 26 Genoscan Study Group. Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. Gastroenterology 2012; 143:1244-52.e1-12.
Jul 27, 2012Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection
Jul 27, 2012Gastroenterology 2012; 143:1244-52.e1-12
Patin Etienne, Stewart Graeme, Booth David R, George Jacob, Casanova Jean-Laurent, Bréchot Christian, Rice Charles M, Talal Andrew H, Jacobson Ira M, Bourlière Marc, Theodorou Ioannis, Poynard Thierry, Negro Francesco, Pol Stanislas, Bochud Pierre-Yves, Abel Laurent, Swiss Hepatitis C Cohort Study Group, International Hepatitis C Genetics Consortium, Suppiah Vijayaprakash, Martinetti Gladys, Hirsch Hans, Kutalik Zoltán, Guergnon Julien, Bibert Stéphanie, Nalpas Bertrand, Jouanguy Emmanuelle, Munteanu Mona, Bousquet Laurence, Argiro Laurent, Halfon Philippe, Boland Anne, Mullhaupt Beat, Semela David, Dufour Jean-François, Heim Markus H, Moradpour Darius, Cerny Andreas, Malinverni Raffaele, French ANRS HC EP 26 Genoscan Study Group
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Gonvers J, Troilliet N, Negro F, Monnat M, Malinverni R, Dutoit V, Dufour F, Chuard C, Chave J, Cerny A, Borovicka J, Bernasconi E, Genné D, Mullhaupt B, Cavassini M, Heim M, Oneta C. Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. Swiss Med Wkly 2010; 140:w13055.
Jul 19, 2010Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Jul 19, 2010Swiss Med Wkly 2010; 140:w13055
Gonvers Jean-Jacques, Troilliet Nicolas, Negro Francesco, Monnat Martine, Malinverni Raffaelle, Dutoit Valérie, Dufour François, Chuard Christian, Chave Jean-Philippe, Cerny Andreas, Borovicka Jan, Bernasconi Enos, Genné Daniel, Mullhaupt Beat, Cavassini Matthias, Heim Markus H, Oneta Carl
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Rauch A, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann J, Berg T, Bergmann S, Negro F, Telenti A, Bochud P, Swiss Hepatitis C Cohort Study, Heim M, Günthard H, Furrer H, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour J, Swiss HIV Cohort Study. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138:1338-45, 1345.e1-7.
Jan 11, 2010Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Jan 11, 2010Gastroenterology 2010; 138:1338-45, 1345.e1-7
Rauch Andri, Hirschel Bernard, Malinverni Raffaele, Moradpour Darius, Mullhaupt Beat, Witteck Andrea, Beckmann Jacques S, Berg Thomas, Bergmann Sven, Negro Francesco, Telenti Amalio, Bochud Pierre-Yves, Swiss Hepatitis C Cohort Study, Heim Markus, Günthard Huldrych F, Furrer Hansjakob, Kutalik Zoltán, Descombes Patrick, Cai Tao, di Iulio Julia, Mueller Tobias, Bochud Murielle, Battegay Manuel, Bernasconi Enos, Borovicka Jan, Colombo Sara, Cerny Andreas, Dufour Jean-François, Swiss HIV Cohort Study
Liposome-based vaccines
Schwendener R, Ludewig B, Cerny A, Engler O. Liposome-based vaccines. Methods in molecular biology (Clifton, N.J.) 2010; 605:163-75.
Jan 1, 2010Liposome-based vaccines
Jan 1, 2010Methods in molecular biology (Clifton, N.J.) 2010; 605:163-75
Schwendener Reto A, Ludewig Burkhard, Cerny Andreas, Engler Olivier
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
Bochud P, Negro F, Francioli P, Malinverni R, Cerny A, Moradpour D, Heim M, Borovicka J, Mullhaupt B, Dufour J, Bochud M, Overbeck K, Cai T, Swiss Hepatitis C Cohort Study Group. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. Journal of hepatology 2009; 51:655-66.
Oct 1, 2009Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
Oct 1, 2009Journal of hepatology 2009; 51:655-66
Bochud Pierre-Yves, Negro Francesco, Francioli Patrick, Malinverni Raffaele, Cerny Andreas, Moradpour Darius, Heim Markus, Borovicka Jan, Mullhaupt Beat, Dufour Jean-François, Bochud Murielle, Overbeck Kathrin, Cai Tao, Swiss Hepatitis C Cohort Study Group